Nu Skin Enterprises, Inc. (NYSE:NUS) declared a quarterly dividend on Thursday, November 8th, Wall Street Journal reports. Stockholders of record on Friday, November 30th will be paid a dividend of 0.365 per share on Wednesday, December 12th. This represents a $1.46 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend is Thursday, November 29th.
Nu Skin Enterprises has raised its dividend payment by an average of 1.4% annually over the last three years and has raised its dividend annually for the last 17 consecutive years. Nu Skin Enterprises has a payout ratio of 40.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Nu Skin Enterprises to earn $3.91 per share next year, which means the company should continue to be able to cover its $1.46 annual dividend with an expected future payout ratio of 37.3%.
Shares of NUS opened at $65.80 on Friday. The company has a market cap of $3.67 billion, a PE ratio of 17.13, a price-to-earnings-growth ratio of 1.68 and a beta of 1.04. Nu Skin Enterprises has a twelve month low of $60.60 and a twelve month high of $88.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.93 and a quick ratio of 1.25.
Several brokerages have recently weighed in on NUS. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, October 23rd. Tigress Financial reaffirmed a “buy” rating on shares of Nu Skin Enterprises in a research note on Wednesday. Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and raised their price target for the stock from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. Citigroup set a $88.00 price target on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Thursday, November 8th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $92.00 price target on shares of Nu Skin Enterprises in a research note on Thursday, November 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has an average rating of “Buy” and an average price target of $86.29.
In related news, General Counsel D Matthew Dorny sold 2,500 shares of the firm’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $82.18, for a total value of $205,450.00. Following the completion of the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 7,500 shares of company stock valued at $568,550 over the last three months. 5.20% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Nu Skin Enterprises, Inc. Plans Quarterly Dividend of $0.37 (NUS)” was first posted by WKRB News and is owned by of WKRB News. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.wkrb13.com/2018/11/24/nu-skin-enterprises-inc-plans-quarterly-dividend-of-0-37-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Story: Stock Symbols Definition, Examples, Lookup
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.